Dr. Justin Taylor (IMAGE)

University of Miami Miller School of Medicine

Dr. Justin Taylor

Caption

“This new compound not only inhibits the cellular molecule BTK, but goes further by taking aim at the target and destroying it,” said Justin Taylor, M.D., Sylvester hematologist-researcher and the study’s senior author. “It’s a new and exciting drug class called BTK degraders.”

Credit

Photo by Sylvester

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.